Mertiva AB, formerly Diamyd Medical AB, is a Sweden-based company active within the healthcare sector. As of August 31, 2013, the Company owned 8% shares of the United-States based Protein Sciences Corporation, as well as 19% shares of Mercodia AB. The Company changed its name in May 2013. Additionally, its subsidiary, Diamyd Therapeutics, was spun off and changed its name to Diamyd Medical.

Employees

Sector

Biotechnology & Medical Research

More about the company

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI

Market Cap	772M 692M 636M 577M 1.08B 73.35B 1.1B 7.59B 3.05B 38.58B 2.9B 2.84B 122B	P/E 2018	28.3x	P/E 2019	13.3x
Enterprise Value	689M 617M 568M 515M 962M 65.46B 980M 6.77B 2.72B 34.43B 2.59B 2.53B 109B	EV / Sales 2018	-	EV / Sales 2019	-
Free-Float	68.13%	Yield 2018 *	-	Yield 2019	-

28/08/17	Sanofi Pasteur Inc. completed the acquisition of Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others.	CI
11/08/17	Diamyd Medical and Cardiff University to Collaborate on Study Monitoring Immune Response in Lymph Node Cells After Administration of Diamyd	CI
11/07/17	Sanofi Pasteur Inc. agreed to acquire Protein Sciences Corporation from Mertiva AB (NGM:MERT MTF A), Ropart Asset Management Funds, Johnson & Johnson, Pfizer Inc. and others for $750 million	CI
29/11/15	Mertiva AB's Equity Buyback announced on December 6, 2012, has expired.	CI
18/12/14	Mertiva AB (OTCPK:DMYD.F) acquired an additional 0.54% stake in Protein Sciences Corporation for $0.62 million.	CI
22/01/14	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
11/10/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
08/10/13	The members of the management of Diamyd, Inc. cancelled the acquisition of 90% stake in Diamyd Inc. from Diamyd Medical AB (OM:DIAM B).	CI
25/09/13	Mertiva AB (OTCPK:DMYD.F) acquired an additional 7.27% stake in Protein Sciences Corporation from Pacific Rim Ventures Co., Ltd. and other shareholders for $8.4 million.	CI
27/08/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic All-Share Index	CI
30/07/13	Mertiva AB(NGM:MERT MTF) dropped from OMX Nordic Small Cap Index	CI
04/07/13	Tranche Update on Mertiva AB (OTCPK:DMYD.F)'s Equity Buyback Plan announced on December 6, 2012.	CI
23/04/13	Diamyd Medical AB Announces Board Appointments	CI

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/14/20 A	Sven Håkan Blomdahl	Buy	Chairman	24,314	0.1775%
10/8/20 A	Sven Håkan Blomdahl	Buy	Chairman	5,378	0.0393%
10/8/20 A	Sven Håkan Blomdahl	Buy	Chairman	821	0.0060%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MERTIVA AB	-	0.00%	-	-	89.46M
WUXI APPTEC CO., LTD.	-0.62%	+0.50%	+33.92%	+60.07%	64.38B
ARGENX SE	+0.35%	+3.04%	+12.64%	+83.62%	56.16B
LONZA GROUP AG	+0.53%	+2.55%	+13.90%	+104.77%	54.16B
IQVIA HOLDINGS INC.	-2.81%	-3.95%	+22.72%	+48.57%	45.33B
BEONE MEDICINES AG	-0.33%	-3.12%	+17.62%	+117.27%	42.25B
REVOLUTION MEDICINES, INC.	+0.55%	+1.93%	+229.73%	+928.00%	40.78B
GENMAB A/S	+3.27%	+47.40%	+110.44%	+94.92%	33.8B
CELLTRION, INC.	+1.22%	-1.39%	+13.92%	+46.95%	32.25B
WUXI BIOLOGICS (CAYMAN) INC.	-1.29%	-1.72%	+21.00%	-6.85%	23.57B
Average	+0.08%	+4.72%	+52.88%	+164.14%	39.28B
Weighted average by Cap.	+0.01%	+3.64%	+49.57%	+162.47%

Mertiva AB Stock

Stocks

MERT A

SE0010023432

Biotechnology & Medical Research

Valuation: Mertiva AB

Latest news: Mertiva AB

Latest insider transactions

Other Biotechnology & Medical Research

Financials

Company Profile

	2018	2019
Net sales	-	-
Net income	25.3M 22.66M 20.84M 18.88M 35.3M 2.4B 35.96M 249M 99.77M 1.26B 94.94M 92.93M 3.98B	76.99M 68.95M 63.43M 57.47M 107M 7.31B 109M 756M 304M 3.85B 289M 283M 12.13B
Net Debt	-253M -226M -208M -189M -353M -24.01B -359M -2.48B -997M -12.63B -949M -929M -39.83B	-83.08M -74.4M -68.44M -62.01M -116M -7.89B -118M -816M -328M -4.15B -312M -305M -13.09B

End-of-day quote NORDIC GROWTH MARKET
- ^SEK	-